• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of July 31, 2013

  • Print
  • Share
  • E-mail
-

Event Detail

Event ID 39199
Product Type Biologics
Status Terminated
Recalling Firm BioLife Plasma Services L.P.
City Van Nuys
State CA
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2007-06-18
Initial Firm Notification of
Consignee or Public
Telephone
Distribution Pattern California

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Source Plasma 5497515,5493852 ,5490646 ,5435494 ,03ATXD8952 , 03ATXD8350 ,030WID5154 ,03ATXD7245 ,030WID4563 , 03ATXD6718 ,92426047 ,03ATXD3475 ,03ATXD2073 , 81844791 ,90023088 ,82899691 ,95029559 ,85507142 , 82896096 ,85505056 ,85500884 ,85498747 ,85486683 , 85485266 ,85481107 ,85479753 ,03HWVA3474 ,03HWVA3195 , 03HWVA2891 ,86233026 ,91312808 ,86228411 ,82430757 , 84098917 ,82429966 ,03PWVA2307 ,03TOHA2187 , 86219440 ,86220002 ,82426606 ,82425036 ,82420130 , 03DOHA1086 ,92648463 ,03TOHA1911 ,86214001 , 03PWVA1959 ,03GNCA2128 ,03DOHA0820 ,92645622 , 03TOHA1495 ,86204644 ,03GNCA1686 ,84087836 , 03TOHA1246 ,92406469 ,86199322 ,03DOHA0556 , 03DOHA0550 ,92641945 ,03TOHA0874 ,03RMIA0654 , 03DOHA0316 ,86186377 ,03DOHA0140 ,03TOHA0491 , 03RMIA0283 ,86177009 ,03RMIA0029 ,03TOHA0119 , 86175647 ,86166454 ,86165099 ,80447573D ,78336018 , 83706882D ,86155540 ,85432956D ,80442387 ,78333659 , 83703348D ,86150835 ,02DOHA3331 ,80438250D , 78331532 ,02DOHA3186 ,86141208 ,80433217D , 78440258D ,86136051D ,02LKYB2845 ,02LKYB2784 , 84811394D ,84811417D ,78438170T ,02DIAD2181 , 02RVAB6902 ,78436657T ,84805331D ,84805355D , 02LKYB2562 ,02GMIG0005 ,02MWII0872 ,02RVAB6689 , 02LKYB2536 ,02MWII0572 ,02RVAB6486 ,84795588D , 84792952D ,84789907 ,84788535D ,91056498 , 02RVAB6064 ,85408876D ,70551013D ,02LKYB1703 , 02LKYB1587 ,80392118D ,02FNDH0949 ,02HHIC0478 , 02HHIC0177 ,02LKYB1337 ,02HHIC0044 ,020NEA2959 , 020NEA2931 ,02BVAA6836 ,02HHIB9703 ,02BVAA6692 , 020NEA2804 ,68262181D ,68262754D ,91269874 , 020NEA2697 ,71336855D ,68262167D ,02BVAA6395 , 91227164 ,68260965D ,68260293D ,020NEA2582 , 68259877D ,83308802D ,71334868D ,68259303D , 020NEA2586 ,02BVAA6300 ,68257927D ,83307744D , 77683762D ,77684066D ,68258269 ,77682123D , 1330631D ,02BVAA6027 ,71328522D ,68253257D , 02BVAA5920 ,77690296D ,66915546 ,91007322 , 71323985D ,02BVAA5695 ,90436505D ,020NEA2729 , 02BVAA5468 ,02BVAA5367 ,90432507D ,81078882D , 02BVAA5240 ,90200380 ,81073832D ,67978755D , 66903741 ,02BVAA5104 ,67977055D ,02BVAA5019 , 02BVAA4969 ,81064540D ,02BVAA4876 ,69045165D , 66898252 ,02BVAA4692 ,78119178D ,02BVAA4628 , 02BVAA4570 ,78115538D ,70515428D ,02BVAA4531 , 80318767D ,02BVAA4342 ,78108844 ,80315599D , 78106499 ,70512298D ,90084973 ,78976757T , 78976344T ,90082351 ,02BVAA3966 ,77976543D , 78973367T ,78972377T ,78863408 ,77899798 , 02LKYB0451 ,77896940 ,78861435 ,02RMIA8056 , 78970311T ,02RMIA7895 ,77891143 ,70037081D , 77328847 ,77867476 ,79916813D ,70031980D , 78967007D ,80275343 ,70026634D ,77325211 , 80272328D ,79907736D ,77322890 ,81226528D , 02GNCA7174 ,74021680D ,80266624D ,70017588D , 79902946D ,66505969D ,77321657 ,70012835D , 81221325D ,79899161D ,66502142D ,81216024D , 66497936D ,77320247 ,81211418D ,77318718 , 02GNCA5866 ,78993907T ,81206643D ,02GNCA5693 , 77316936 ,77315496 ,02RVAA5459 ,02RVAA5130 , 02RVAA4842 ,76731297D ,02RVAA4667 ,02RVAA4250 , 02RVAA4209 ,02RVAA4017 ,02RVAA4030 ,6010210821 , 80857105D ,75384067 ,020NEA0135 ,75940010 , 75937270 ,75930646 ,75379285 ,75371470 , 74858248 ,76559648 ,ZR083538 ,63020052D , 63015331D Class II Blood products, which were not quarantined subsequent to receiving information regarding a post donation information related to vCJD risk, were distributed. 269 units B-1932-13
-
-